Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)

meta-iodobenzylguanidine (MIBG) radiolabelled with iodine-131 is used for diagnosis and treatment of neuroadrenergic neoplasms such as phaeochromocytoma and neuroblastoma. In addition, non-radiolabelled MIBG, administered i.v., is used in several clinical studies. These include palliation of the car...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuin, A, Rutgers, M, Valk, M A van der, Beijnen, J H, Smets, L A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362668/
https://www.ncbi.nlm.nih.gov/pubmed/10070872
http://dx.doi.org/10.1038/sj.bjc.6690128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362668/
https://www.ncbi.nlm.nih.gov/pubmed/10070872
http://dx.doi.org/10.1038/sj.bjc.6690128

Ejemplares similares